Cargando…
Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
Introduction: Dalbavancin is an antibiotic administered by intravenous infusion weekly or bi-weekly and is currently FDA-approved only for treatment of skin and soft-tissue infections. It has shown promise, but is not considered the standard of care, for bacteremia and infective endocarditis (IE), w...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602462/ https://www.ncbi.nlm.nih.gov/pubmed/33076275 http://dx.doi.org/10.3390/antibiotics9100700 |